BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10150308)

  • 1. Postmenopausal estrogen and cardiovascular disease.
    Stampfer MJ; Grodstein F; Bechtel S
    Contemp Intern Med; 1994 Sep; 6(9):47-56, 59. PubMed ID: 10150308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal hormone replacement therapy: does the progestin make a difference?
    Fylstra DL
    J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormone replacement therapy: estrogen after menopause.
    Gibaldi M
    Pharmacotherapy; 1996; 16(3):366-75. PubMed ID: 8726594
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women.
    Psaty BM; Heckbert SR; Atkins D; Siscovick DS; Koepsell TD; Wahl PW; Longstreth WT; Weiss NS; Wagner EH; Prentice R
    Arch Intern Med; 1993 Jun; 153(12):1421-7. PubMed ID: 8512434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormone replacement therapy of menopause in women with vascular risk factors].
    Charbonnel B
    Diabete Metab; 1993; 19(4):387-90. PubMed ID: 8293865
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacology of estrogens and progestogens and cardiovascular risk].
    Boissel JP; Cornu C
    Therapie; 1999; 54(3):387-92. PubMed ID: 10500456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversial aspects of hormone replacement therapy upon cardiovascular mortality and morbidity of women in menopause.
    Rosano GM; Mercuro G
    G Ital Cardiol; 1999 Sep; 29(9):999-1003. PubMed ID: 10514956
    [No Abstract]   [Full Text] [Related]  

  • 9. [Estrogens and cardiovascular diseases in the postmenopause].
    Riedel M; Rafflenbeul W
    Dtsch Med Wochenschr; 1992 Jul; 117(31-32):1205-11. PubMed ID: 1644017
    [No Abstract]   [Full Text] [Related]  

  • 10. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
    Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary prevention in coronary diseases. Viewpoint of the gynecological endocrinologist].
    Hänggi W
    Praxis (Bern 1994); 1997 Jan; 86(5):145-9. PubMed ID: 9064732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmenopausal hormone therapy and cardiovascular risk.
    VandeKieft G
    J Fam Pract; 1996 Nov; 43(5):437-8. PubMed ID: 8917138
    [No Abstract]   [Full Text] [Related]  

  • 13. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
    J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The controversy over estrogen replacement therapy: an update on clinical trials.
    Gnatuk CL
    Curr Womens Health Rep; 2002 Apr; 2(2):89-94. PubMed ID: 12116607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
    Lacut K; Oger E
    Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Further recognize the benefit and risk of postmenopausal hormone replacement therapy on atherosclerotic cardiovascular diseases].
    Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 Jun; 37(6):321-3. PubMed ID: 12947970
    [No Abstract]   [Full Text] [Related]  

  • 18. The pharmacokinetics and efficacy of different estrogens are not equivalent.
    Ansbacher R
    Am J Obstet Gynecol; 2001 Feb; 184(3):255-63. PubMed ID: 11228470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preserving cardiovascular benefits of hormone replacement therapy.
    Bush TL
    J Reprod Med; 2000 Mar; 45(3 Suppl):259-73. PubMed ID: 10756507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.